<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/">
<channel>
<title>Press Release Service And Distribution - MarketPressRelease.com</title>
<atom:link href="http://www.marketpressrelease.com/rss2" rel="self" type="application/rss+xml" /> <link>http://www.marketpressrelease.com</link>
<description>Free press release distribution site where pr and marketing professionals can submit press release online for reaching media persons and prospective customers.</description>
<pubDate>Thu, 24 May 2012 12:30:56 +0100</pubDate>
<generator>http://www.kenovate.com</generator>
<language>en</language>
<sy:updatePeriod>daily</sy:updatePeriod>
<sy:updateFrequency>1</sy:updateFrequency>

<item>
<title>A Guidebook of Registration Application for Imported Biological Products</title>
<link>http://www.marketpressrelease.com/A-Guidebook-of-Registration-Application-for-Imported-Biological-Products-1336783264.html</link>
<pubDate>Thu, 24 May 2012 12:30:57 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Biotech]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/A-Guidebook-of-Registration-Application-for-Imported-Biological-Products-1336783264.html</guid>
<description>A Guidebook of Registration Application for Imported Biological Products is the fourth guidebook of the China Pharmaceutical Guidebook Series.</description>
</item>
<item>
<title>Indian HIV Diagnostic Market Expected to Grow Exponentially</title>
<link>http://www.marketpressrelease.com/Indian-HIV-Diagnostic-Market-Expected-to-Grow-Exponentially-1335506980.html</link>
<pubDate>Thu, 24 May 2012 12:30:57 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Biotech]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Indian-HIV-Diagnostic-Market-Expected-to-Grow-Exponentially-1335506980.html</guid>
<description>Although elisa based tests currently dominate this market, the popularity of rapid tests as a result of their ease of use and faster results is increasing rapidly in the country.</description>
</item>
<item>
<title>Chinese Diabetes Market to Reach USD 2.8 Billion by 2015</title>
<link>http://www.marketpressrelease.com/Chinese-Diabetes-Market-to-Reach-USD-28-Billion-by-2015-1335259453.html</link>
<pubDate>Thu, 24 May 2012 12:30:57 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Biotech]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Chinese-Diabetes-Market-to-Reach-USD-28-Billion-by-2015-1335259453.html</guid>
<description>A new report expects the Chinese diabetes market to grow exponentially in the coming years.</description>
</item>
<item>
<title>Management of Cold Chains Will be Critical for the Growth of the Healthcare Industry</title>
<link>http://www.marketpressrelease.com/Management-of-Cold-Chains-Will-be-Critical-for-the-Growth-of-the-Healthcare-Industry-1334828257.html</link>
<pubDate>Thu, 24 May 2012 12:30:57 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Biotech]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Management-of-Cold-Chains-Will-be-Critical-for-the-Growth-of-the-Healthcare-Industry-1334828257.html</guid>
<description>Although its clear that the market for healthcare products are poised for robust growth, a strong and reliable cold chain logistics infrastructure will be critical for the sectors development</description>
</item>
<item>
<title>Supply Shortage of Raw Materials Threatening the Growth of the Global Rare Earth Magnets Industry</title>
<link>http://www.marketpressrelease.com/Supply-Shortage-of-Raw-Materials-Threatening-the-Growth-of-the-Global-Rare-Earth-Magnets-Industry-1334571740.html</link>
<pubDate>Thu, 24 May 2012 12:30:57 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Biotech]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Supply-Shortage-of-Raw-Materials-Threatening-the-Growth-of-the-Global-Rare-Earth-Magnets-Industry-1334571740.html</guid>
<description>A new study expects a robust growth in the future demand of rare earth based magnets.  A supply shortage of essential raw materials, however, may endanger the growth of this entire industry</description>
</item>
<item>
<title>Biosimilars Expected to Take Toll on Amgen</title>
<link>http://www.marketpressrelease.com/Biosimilars-Expected-to-Take-Toll-on-Amgen-1334035948.html</link>
<pubDate>Thu, 24 May 2012 12:30:57 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Biotech]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Biosimilars-Expected-to-Take-Toll-on-Amgen-1334035948.html</guid>
<description>Biosimilar competition to multiple drugs is expected to reduce Amgens sales by nearly US$ 9 Billion during 2013-2020</description>
</item>
<item>
<title>Significant Strides Toward Better and Cost-Effective Cancer Diagnostic</title>
<link>http://www.marketpressrelease.com/Significant-Strides-Toward-Better-and-Cost-Effective-Cancer-Diagnostic-1332348183.html</link>
<pubDate>Thu, 24 May 2012 12:30:57 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Biotech]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Significant-Strides-Toward-Better-and-Cost-Effective-Cancer-Diagnostic-1332348183.html</guid>
<description>San Diego-Based Trovagene, Inc. Banking on Patented Urine Test to Achieve Dual Goals by End of Year</description>
</item>
<item>
<title>The Market For Diabetes Drugs in India Expected to Grow Robustly</title>
<link>http://www.marketpressrelease.com/The-Market-For-Diabetes-Drugs-in-India-Expected-to-Grow-Robustly-1332231516.html</link>
<pubDate>Thu, 24 May 2012 12:30:57 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Biotech]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/The-Market-For-Diabetes-Drugs-in-India-Expected-to-Grow-Robustly-1332231516.html</guid>
<description>Driven by a large diabetes population, improving healthcare infrastructure and a bright outlook for patented drugs; the diabetes market in India is expected to grow exponentially in the coming years.</description>
</item>
<item>
<title>Rising Diabetes Epidemic offering huge Opportunities for Drug Manufacturers in China</title>
<link>http://www.marketpressrelease.com/Rising-Diabetes-Epidemic-offering-huge-Opportunities-for-Drug-Manufacturers-in-China-1332131445.html</link>
<pubDate>Thu, 24 May 2012 12:30:57 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Biotech]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Rising-Diabetes-Epidemic-offering-huge-Opportunities-for-Drug-Manufacturers-in-China-1332131445.html</guid>
<description>With the Chinese population getting richer, fatter and less mobile; there has been a surge in the prevalence of diabetes in recent year</description>
</item>
<item>
<title>Gain a Deep Insight into the Global Healthcare Cold Chain Logistic Services Market</title>
<link>http://www.marketpressrelease.com/Gain-a-Deep-Insight-into-the-Global-Healthcare-Cold-Chain-Logistic-Services-Market-1331534244.html</link>
<pubDate>Thu, 24 May 2012 12:30:57 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Biotech]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Gain-a-Deep-Insight-into-the-Global-Healthcare-Cold-Chain-Logistic-Services-Market-1331534244.html</guid>
<description>Driven by a strong demand of biopharmaceuticals, vaccines and clinical trial materials; the global market for healthcare cold chain logistic services is expected to grow exponentially in the coming years.</description>
</item>
<item>
<title>IMARC Group Releases the Most Comprehensive Study on the US Follow-on Biologics Market</title>
<link>http://www.marketpressrelease.com/IMARC-Group-Releases-the-Most-Comprehensive-Study-on-the-US-Follow-on-Biologics-Market-1331027401.html</link>
<pubDate>Thu, 24 May 2012 12:30:57 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Biotech]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/IMARC-Group-Releases-the-Most-Comprehensive-Study-on-the-US-Follow-on-Biologics-Market-1331027401.html</guid>
<description>The study entitled Biosimilar/Follow-on Biologics Market Report &amp;amp;#38; Forecast: A Focus on the US (2011-2020) provides a comprehensive insight into the US biosimilar market</description>
</item>
<item>
<title>Indian Immunodiagnostics Market to Reach US$ 264 Million by 2016</title>
<link>http://www.marketpressrelease.com/Indian-Immunodiagnostics-Market-to-Reach-US-264-Million-by-2016-1330939831.html</link>
<pubDate>Thu, 24 May 2012 12:30:57 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Biotech]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Indian-Immunodiagnostics-Market-to-Reach-US-264-Million-by-2016-1330939831.html</guid>
<description>IMARC Group has recently released one of the most comprehensive market studies on the Indian Immunodiagnostics market.</description>
</item>
<item>
<title>Trovagene Gets Big Boost for Triumvirate of Leaders and Advanced Technology</title>
<link>http://www.marketpressrelease.com/Trovagene-Gets-Big-Boost-for-Triumvirate-of-Leaders-and-Advanced-Technology-1330712638.html</link>
<pubDate>Thu, 24 May 2012 12:30:57 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Biotech]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Trovagene-Gets-Big-Boost-for-Triumvirate-of-Leaders-and-Advanced-Technology-1330712638.html</guid>
<description>Bio Med Report Cites Molecular Diagnostic Firm\s \&amp;quot;Experienced, Respected\&amp;quot; Biotech Team</description>
</item>
<item>
<title>Efficient, Less Costly  Urine Diagnostic for Cancer on the Way at Trovagene, Inc.</title>
<link>http://www.marketpressrelease.com/Efficient-Less-Costly-Urine-Diagnostic-for-Cancer-on-the-Way-at-Trovagene-Inc-1329233978.html</link>
<pubDate>Thu, 24 May 2012 12:30:57 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Biotech]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Efficient-Less-Costly-Urine-Diagnostic-for-Cancer-on-the-Way-at-Trovagene-Inc-1329233978.html</guid>
<description>Novel Tests Planned for End of Year and New Lab to Develop Tests in Other Areas</description>
</item>
<item>
<title>GenScript Was the Most Frequently Referred Biology Contract Research Organization</title>
<link>http://www.marketpressrelease.com/GenScript-Was-the-Most-Frequently-Referred-Biology-Contract-Research-Organization-1328160005.html</link>
<pubDate>Thu, 24 May 2012 12:30:57 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Biotech]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/GenScript-Was-the-Most-Frequently-Referred-Biology-Contract-Research-Organization-1328160005.html</guid>
<description>GenScript USA Inc., an internationally recognized biology contract research organization (CRO), became the most frequently referred biology CRO in the world by peer-reviewed journal articles in the year 2011.</description>
</item>
<item>
<title>Bureaucratic and Technical Hurdles Constraining the Growth of the Indian Smart Cards Market</title>
<link>http://www.marketpressrelease.com/Bureaucratic-and-Technical-Hurdles-Constraining-the-Growth-of-the-Indian-Smart-Cards-Market-1328079174.html</link>
<pubDate>Thu, 24 May 2012 12:30:57 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Biotech]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Bureaucratic-and-Technical-Hurdles-Constraining-the-Growth-of-the-Indian-Smart-Cards-Market-1328079174.html</guid>
<description>A number of smart card projects such as the UID, E-passports, EPFO, etc have been delayed or cancelled due to problems like lack of funds, technical issues, legal wrangling, etc.</description>
</item>
<item>
<title>Most of the Marketed Monoclonal Antibodies Lack a Patent Protection in India</title>
<link>http://www.marketpressrelease.com/Most-of-the-Marketed-Monoclonal-Antibodies-Lack-a-Patent-Protection-in-India-1327398599.html</link>
<pubDate>Thu, 24 May 2012 12:30:57 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Biotech]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Most-of-the-Marketed-Monoclonal-Antibodies-Lack-a-Patent-Protection-in-India-1327398599.html</guid>
<description>Biosimilar manufacturers are currently free to copy and manufacture most of the globally marketed therapeutic monoclonal antibodies in India</description>
</item>
<item>
<title>The Penetration of Biosimilars in the US Will Vary Across Different Biological Classes</title>
<link>http://www.marketpressrelease.com/The-Penetration-of-Biosimilars-in-the-US-Will-Vary-Across-Different-Biological-Classes-1326351211.html</link>
<pubDate>Thu, 24 May 2012 12:30:57 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Biotech]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/The-Penetration-of-Biosimilars-in-the-US-Will-Vary-Across-Different-Biological-Classes-1326351211.html</guid>
<description>The volume penetration of biosimilars in the US will strongly depend upon the complexity of the molecule, the patient pool that it caters and the extent of savings it brings to payers and providers</description>
</item>
<item>
<title>GenScript sponsors 2011 iGEM undergraduate Synthetic Biology competition</title>
<link>http://www.marketpressrelease.com/GenScript-sponsors-2011-iGEM-undergraduate-Synthetic-Biology-competition-1323996795.html</link>
<pubDate>Thu, 24 May 2012 12:30:57 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Biotech]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/GenScript-sponsors-2011-iGEM-undergraduate-Synthetic-Biology-competition-1323996795.html</guid>
<description>Internationally recognized biology contract research organization GenScript USA Inc. congratulates the achievements of eight teams we sponsored in 2011 iGEM undergraduate synthetic biology competition.</description>
</item>
<item>
<title>Synergy Pharmaceuticals Seeks $500 milion in Lawsuit Against Ironwood Pharmaceuticals</title>
<link>http://www.marketpressrelease.com/Synergy-Pharmaceuticals-Seeks-500-milion-in-Lawsuit-Against-Ironwood-Pharmaceuticals-1323779131.html</link>
<pubDate>Thu, 24 May 2012 12:30:57 +0100</pubDate>
<dc:creator>marketpressrelease</dc:creator>
<category><![CDATA[Biotech]]></category>
<guid isPermaLink="true">http://www.marketpressrelease.com/Synergy-Pharmaceuticals-Seeks-500-milion-in-Lawsuit-Against-Ironwood-Pharmaceuticals-1323779131.html</guid>
<description>Accuses Ironwood of Fraud, Unfair Competition and Unjust Enrichment in Gastrointestinal Patent Case</description>
</item>
</channel>
</rss>

